Literature DB >> 33676925

Simplicity is the Ultimate Sophistication-Crosstalk of Post-translational Modifications on the RNA Polymerase II.

Mukesh Kumar Venkat Ramani1, Wanjie Yang1, Seema Irani1, Yan Zhang2.   

Abstract

The highly conserved C-terminal domain (CTD) of the largest subunit of RNA polymerase II comprises a consensus heptad (Y1S2P3T4S5P6S7) repeated multiple times. Despite the simplicity of its sequence, the essential CTD domain orchestrates eukaryotic transcription and co-transcriptional processes, including transcription initiation, elongation, and termination, and mRNA processing. These distinct facets of the transcription cycle rely on specific post-translational modifications (PTM) of the CTD, in which five out of the seven residues in the heptad repeat are subject to phosphorylation. A hypothesis termed the "CTD code" has been proposed in which these PTMs and their combinations generate a sophisticated landscape for spatiotemporal recruitment of transcription regulators to Pol II. In this review, we summarize the recent experimental evidence understanding the biological role of the CTD, implicating a context-dependent theme that significantly enhances the ability of accurate transcription by RNA polymerase II. Furthermore, feedback communication between the CTD and histone modifications coordinates chromatin states with RNA polymerase II-mediated transcription, ensuring the effective and accurate conversion of information into cellular responses.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  RNA polymerase II; crosstalk; histone; phosphorylation; transcription

Mesh:

Substances:

Year:  2021        PMID: 33676925      PMCID: PMC8184622          DOI: 10.1016/j.jmb.2021.166912

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   6.151


  135 in total

1.  Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme.

Authors:  C K Ho; S Shuman
Journal:  Mol Cell       Date:  1999-03       Impact factor: 17.970

2.  The C-terminal domain phosphatase and transcription elongation activities of FCP1 are regulated by phosphorylation.

Authors:  Erika M Friedl; William S Lane; Hediye Erdjument-Bromage; Paul Tempst; Danny Reinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

3.  Regulation of CDK7 substrate specificity by MAT1 and TFIIH.

Authors:  K Y Yankulov; D L Bentley
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

4.  The CTD code.

Authors:  Stephen Buratowski
Journal:  Nat Struct Biol       Date:  2003-09

Review 5.  Pinning down proline-directed phosphorylation signaling.

Authors:  Kun Ping Lu; Yih Cherng Liou; Xiao Zhen Zhou
Journal:  Trends Cell Biol       Date:  2002-04       Impact factor: 20.808

6.  Cooperative interaction of transcription termination factors with the RNA polymerase II C-terminal domain.

Authors:  Bradley M Lunde; Steve L Reichow; Minkyu Kim; Hyunsuk Suh; Thomas C Leeper; Fan Yang; Hannes Mutschler; Stephen Buratowski; Anton Meinhart; Gabriele Varani
Journal:  Nat Struct Mol Biol       Date:  2010-09-05       Impact factor: 15.369

7.  Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast.

Authors:  Zu-Wen Sun; C David Allis
Journal:  Nature       Date:  2002-06-23       Impact factor: 49.962

8.  Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex.

Authors:  Kehui Xiang; Takashi Nagaike; Song Xiang; Turgay Kilic; Maia M Beh; James L Manley; Liang Tong
Journal:  Nature       Date:  2010-09-22       Impact factor: 49.962

9.  BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1.

Authors:  Helen Jayne Susan Stewart; Gillian Abigail Horne; Sarah Bastow; Timothy James Telfer Chevassut
Journal:  Cancer Med       Date:  2013-10-31       Impact factor: 4.452

10.  Phosphorylation induces sequence-specific conformational switches in the RNA polymerase II C-terminal domain.

Authors:  Eric B Gibbs; Feiyue Lu; Bede Portz; Michael J Fisher; Brenda P Medellin; Tatiana N Laremore; Yan Jessie Zhang; David S Gilmour; Scott A Showalter
Journal:  Nat Commun       Date:  2017-05-12       Impact factor: 14.919

View more
  6 in total

Review 1.  The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation.

Authors:  Silvia Strocchi; Francesca Reggiani; Giulia Gobbi; Alessia Ciarrocchi; Valentina Sancisi
Journal:  Oncogene       Date:  2022-06-15       Impact factor: 8.756

2.  Genome-Wide Regulations of the Preinitiation Complex Formation and Elongating RNA Polymerase II by an E3 Ubiquitin Ligase, San1.

Authors:  Priyanka Barman; Rwik Sen; Chhabi K Govind; Amala Kaja; Jannatul Ferdoush; Shalini Guha; Sukesh R Bhaumik
Journal:  Mol Cell Biol       Date:  2021-10-18       Impact factor: 5.069

Review 3.  What's all the phos about? Insights into the phosphorylation state of the RNA polymerase II C-terminal domain via mass spectrometry.

Authors:  Blase M LeBlanc; R Yvette Moreno; Edwin E Escobar; Mukesh Kumar Venkat Ramani; Jennifer S Brodbelt; Yan Zhang
Journal:  RSC Chem Biol       Date:  2021-06-03

4.  Evaluating Spatiotemporal Dynamics of Phosphorylation of RNA Polymerase II Carboxy-Terminal Domain by Ultraviolet Photodissociation Mass Spectrometry.

Authors:  Edwin E Escobar; Mukesh Kumar Venkat Ramani; Yan Zhang; Jennifer S Brodbelt
Journal:  J Am Chem Soc       Date:  2021-05-31       Impact factor: 16.383

5.  Live imaging of transcription sites using an elongating RNA polymerase II-specific probe.

Authors:  Satoshi Uchino; Yuma Ito; Yuko Sato; Tetsuya Handa; Yasuyuki Ohkawa; Makio Tokunaga; Hiroshi Kimura
Journal:  J Cell Biol       Date:  2021-12-02       Impact factor: 10.539

6.  TOR complex 2 contributes to regulation of gene expression via inhibiting Gcn5 recruitment to subtelomeric and DNA replication stress genes.

Authors:  Adiel Cohen; Emese Pataki; Martin Kupiec; Ronit Weisman
Journal:  PLoS Genet       Date:  2022-02-14       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.